Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children.

O'Dorisio MS, Khanna G, Bushnell D.

Cancer Metastasis Rev. 2008 Dec;27(4):665-77. doi: 10.1007/s10555-008-9153-8. Review.

PMID:
18581060
[PubMed - indexed for MEDLINE]
2.

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.

Kaltsas GA, Mukherjee JJ, Grossman AB.

Ann Oncol. 2001;12 Suppl 2:S47-50. Review.

PMID:
11762352
[PubMed - indexed for MEDLINE]
3.

Imaging of neuroendocrine tumors.

Rufini V, Calcagni ML, Baum RP.

Semin Nucl Med. 2006 Jul;36(3):228-47. Review.

PMID:
16762613
[PubMed - indexed for MEDLINE]
4.

Experience with indium-111 and yttrium-90-labeled somatostatin analogs.

Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R.

Curr Pharm Des. 2002;8(20):1781-807. Review.

PMID:
12171531
[PubMed - indexed for MEDLINE]
5.

MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.

Pashankar FD, O'Dorisio MS, Menda Y.

J Nucl Med. 2005 Jan;46 Suppl 1:55S-61S. Review.

PMID:
15653652
[PubMed - indexed for MEDLINE]
Free Article
6.

Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.

Oberg K, Eriksson B.

Best Pract Res Clin Endocrinol Metab. 2005 Jun;19(2):265-76. Review.

PMID:
15763700
[PubMed - indexed for MEDLINE]
7.

Nuclear medicine imaging of endocrine neoplasms.

Wong KK, Kandathil A, Marzola MC, Gross MD, Rubello D.

Nucl Med Commun. 2014 Jan;35(1):1-19. doi: 10.1097/MNM.0000000000000021. Review.

PMID:
24201551
[PubMed - indexed for MEDLINE]
8.

Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors.

Sisson JC, Yanik GA.

Semin Nucl Med. 2012 May;42(3):171-84. doi: 10.1053/j.semnuclmed.2011.11.004. Review.

PMID:
22475426
[PubMed - indexed for MEDLINE]
9.

Imaging advances in the diagnosis of endocrine neoplasia.

Scott BA, Gatenby RA.

Curr Opin Oncol. 1998 Jan;10(1):37-42. Review.

PMID:
9466483
[PubMed - indexed for MEDLINE]
10.

Functional assessment in the multimodality imaging of pancreatic neuro-endocrine tumours.

Bhate K, Mok WY, Tran K, Khan S, Al-Nahhas A.

Minerva Endocrinol. 2010 Mar;35(1):17-25. Review.

PMID:
20386524
[PubMed - indexed for MEDLINE]
11.

Contemporary approach to diagnosis and treatment of neuroblastoma.

Charron M.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):40-52. Review.

PMID:
23474634
[PubMed - indexed for MEDLINE]
12.

New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.

Virgolini I, Traub T, Leimer M, Novotny C, Pangerl T, Ofluoglu S, Halvadjieva E, Smith-Jones P, Flores J, Li SR, Angelberger P, Havlik E, Andreae F, Raderer M, Kurtaran A, Niederle B, Dudczak R.

Q J Nucl Med. 2000 Mar;44(1):50-8. Review.

PMID:
10932601
[PubMed - indexed for MEDLINE]
13.

Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.

Modlin IM, Cornelius E, Lawton GP.

Arch Surg. 1995 Apr;130(4):367-73; discussion 373-4. Review.

PMID:
7710334
[PubMed - indexed for MEDLINE]
14.

Nuclear medicine applications for neuroendocrine tumors.

Chatal JF, Le Bodic MF, Kraeber-Bodéré F, Rousseau C, Resche I.

World J Surg. 2000 Nov;24(11):1285-9. Review.

PMID:
11038195
[PubMed - indexed for MEDLINE]
15.

New trends in peptide receptor radioligands.

Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Andreae F, Kurtaran A, Dudczak R.

Q J Nucl Med. 2001 Jun;45(2):153-9. Review.

PMID:
11476164
[PubMed - indexed for MEDLINE]
16.

¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.

Bomanji JB, Papathanasiou ND.

Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S113-25. doi: 10.1007/s00259-011-2013-8. Review.

PMID:
22388626
[PubMed - indexed for MEDLINE]
17.

Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals.

Bombardieri E, Coliva A, Maccauro M, Seregni E, Orunesu E, Chiti A, Lucignani G.

Q J Nucl Med Mol Imaging. 2010 Feb;54(1):3-15. Review.

PMID:
20168282
[PubMed - indexed for MEDLINE]
Free Article
18.

FDG-PET/CT in pediatric solid tumors.

Franzius C.

Q J Nucl Med Mol Imaging. 2010 Aug;54(4):401-10. Review.

PMID:
20823808
[PubMed - indexed for MEDLINE]
19.

Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors.

Khan MU, Morse M, Coleman RE.

Q J Nucl Med Mol Imaging. 2008 Dec;52(4):441-54. Review.

PMID:
19088697
[PubMed - indexed for MEDLINE]
Free Article
20.

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP.

Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73. doi: 10.1677/ERC-09-0078. Print 2010 Mar. Review.

PMID:
19995807
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk